EMG
KURA icon

Ellington Management Group’s Kura Oncology KURA Stock Holding History

Ellington Management Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-27,100
Closed -$270K – 249
2020
Q1 		$270K Buy
+27,100
New +$310K 0.06% 353
2017
Q4 		– Sell
-14,200
Closed -$212K – 706
2017
Q3 		$212K Buy
+14,200
New +$133K 0.04% 508

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Ellington Management Group's KURA Position: Q2 2020 in Review

Ellington Management Group sold out of Kura Oncology (KURA) in Q2 2020, closing a stake of 27,100 shares — an estimated $270K sold.

Ellington Management Group first reported a position in KURA in Q3 2017 and held it in 2 quarters. The position peaked at $270K in Q1 2020. 134 funds tracked by Wall St. Rank hold KURA as of Q2 2020.

  • Ellington Management Group reported no remaining Kura Oncology position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 27,100 Kura Oncology shares in Q2 2020, an estimated $270K.
  • Ellington Management Group first reported a position in Kura Oncology in Q3 2017 and held it in 2 quarters.
  • Ellington Management Group's Kura Oncology position peaked at $270K in Q1 2020.
  • 134 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.